Human/Mouse/Rat Total AMPK alpha 1 DuoSet IC ELISA

Human/Mouse/Rat Total AMPK alpha 1 DuoSet IC ELISA Summary

* Provided that the recommended microplates, buffers, diluents, substrates and solutions are used, and the assay is run as summarized in the Assay Procedure provided.

Product Features

• Optimized capture and detection antibody pairings with recommended concentrations save lengthy development time
• Development protocols are provided to guide further assay optimization
• Assay can be customized to your specific needs
• Available in 2, 5, and 15- (96-well) plate pack sizes
• Economical alternative to Western blot

Kit Content

• Capture Antibody
• Conjugated Detection Antibody
• Calibrated Immunoassay Standard or Control
• Streptavidin-HRP

Other Reagents Required

Scientific Data

ELISA View Larger

Standard Curve

N/A View Larger

Quantification of AMPK alpha1 in human cell lysates. Lysates prepared from MCF-7 human breast cancer cells, MDA-MB-468 human breast cancer cells, and HeLa human cervical epithelial carcinoma cells were quantified with this DuoSet IC ELISA. The same lysates were also immunoblotted (inset) with anti-AMPK alpha1 polyclonal antibody (Catalog # AF3197). The DuoSet IC ELISA results correlate well with the relative amounts of AMPK alpha1 detected by Western blot.

N/A View Larger

Quantification of AMPK alpha alpha1 in mouse and rat cell lysates. Lysates prepared from C2C12 mouse myoblast cells, DA3 mouse myeloma cells, and PC-12 rat adrenal pheochromocytoma cells were quantified with this DuoSet IC ELISA. The same lysates were also immunoblotted (inset) with anti-AMPK alpha1 monoclonal antibody (Catalog # MAB3197). The DuoSet IC ELISA results correlate well with the relative amounts of AMPK alpha1 detected by Western blot.

Product Datasheets

Preparation and Storage

Background: AMPK alpha 1

AMP-activated protein kinase (AMPK) is a heterotrimeric complex consisting of a catalytic a subunit and regulatory beta and gamma subunits. Each subunit exists as alternate isoforms (alpha 1, alpha 2, beta 1, beta 2, gamma 1, gamma 2, gamma 3), with all 12 combinations capable of forming complexes. The catalytic a subunit of AMPK is activated allosterically by AMP and by phosphorylation via the AMPK kinase LKB1. Active AMPK downregulates anabolic pathways such as fatty acid, triglyceride, and cholesterol synthesis, and up-regulates catabolic pathways such as glycolysis and fatty acid oxidation. AMPK's role in metabolic regulation has implicated this serine/threonine kinase as a therapeutic target in heart disease, obesity, and diabetes.